Is It Too Late To Consider Buying Bruker Corporation (NASDAQ:BRKR)?

By
Simply Wall St
Published
April 12, 2022
NasdaqGS:BRKR
Source: Shutterstock

While Bruker Corporation (NASDAQ:BRKR) might not be the most widely known stock at the moment, it received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US$80.99 at one point, and dropping to the lows of US$61.72. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Bruker's current trading price of US$63.52 reflective of the actual value of the mid-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Bruker’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

View our latest analysis for Bruker

Is Bruker still cheap?

The stock seems fairly valued at the moment according to my valuation model. It’s trading around 3.13% above my intrinsic value, which means if you buy Bruker today, you’d be paying a relatively reasonable price for it. And if you believe the company’s true value is $61.59, there’s only an insignificant downside when the price falls to its real value. Is there another opportunity to buy low in the future? Since Bruker’s share price is quite volatile, we could potentially see it sink lower (or rise higher) in the future, giving us another chance to buy. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.

What kind of growth will Bruker generate?

earnings-and-revenue-growth
NasdaqGS:BRKR Earnings and Revenue Growth April 12th 2022

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. Bruker's earnings over the next few years are expected to increase by 44%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.

What this means for you:

Are you a shareholder? It seems like the market has already priced in BRKR’s positive outlook, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the track record of its management team. Have these factors changed since the last time you looked at the stock? Will you have enough confidence to invest in the company should the price drop below its fair value?

Are you a potential investor? If you’ve been keeping an eye on BRKR, now may not be the most advantageous time to buy, given it is trading around its fair value. However, the positive outlook is encouraging for the company, which means it’s worth further examining other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. You'd be interested to know, that we found 1 warning sign for Bruker and you'll want to know about this.

If you are no longer interested in Bruker, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Discounted cash flow calculation for every stock

Simply Wall St does a detailed discounted cash flow calculation every 6 hours for every stock on the market, so if you want to find the intrinsic value of any company just search here. It’s FREE.

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.